Stroke and Cholesterol-Reference-Cited by-同舟云学术

Stroke and Cholesterol

Published:2004-06 Issue:6 Volume:35 Page:1526-1526
ISSN:0039-2499
Container-title:Stroke
language:en
Short-container-title:Stroke

Author:

Donnan Geoffrey A.¹,Davis Stephen M.¹

Affiliation:

1. From the National Stroke Research Institute, Austin, and Repatriation Medical Centre and University of Melbourne (G.A.D.), Australia; and Department of Neurology (S.M.D.), Royal Melbourne Hospital and University of Melbourne, Australia.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialised Nursing,Cardiology and Cardiovascular Medicine,Clinical Neurology

Reference5 articles.

1. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial

2. Design and Baseline Characteristics of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study

3. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

4. Lipid Lowering by Simvastatin Induces Regression of Human Atherosclerotic Lesions

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simvastatin induces differentiation in rabbit articular chondrocytes via Wnt/β-catenin pathway;European Journal of Pharmacology;2019-11

2. Subsequent Vascular Events after Ischemic Stroke: The Japan Statin Treatment against Recurrent Stroke—Longitudinal;Journal of Stroke and Cerebrovascular Diseases;2015-02

3. Antithrombotic selection and risk factor management in ischemic stroke and transient ischemic attack;Neurosurgical Focus;2014-01

4. Spotting and treating a stroke;British Journal of Cardiac Nursing;2011-04

5. High-Dose Atorvastatin After Stroke or Transient Ischemic Attack: The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators;Journal of the CardioMetabolic Syndrome;2008-12